Riskpilot← Back to searchSign inGet full accessBiologik ApS
APSActiveCVR 36070498Langs Hegnet 88Other human health activities n.e.c. · NACE 8699Est. 20141 employees
Revenue 2025
DKK 386K
-4% vs 2024
EBITDA margin
78.5%
+821% vs 2024
Equity ratio
73.9%
Financial strength
Net profit 2025
DKK 234K
+763% vs 2024
| Revenue | DKK 386K | -4% |
| EBITDA | DKK 303K | +821% |
| Net profit | DKK 234K | +763% |
| Total assets | DKK 553K | +62% |
| Equity | DKK 409K | +74% |
| Employees | 1 | — |
Legal name
Biologik ApS
CVR number
36070498
Legal form
Anpartsselskab
NACE code
8699 · Other human health activities n.e.c.
Founded
18. august 2014
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er at udføre sundhedsformidling, fx udgive bøger, afholde kurser, foredrag og debatter samt yde konsulentydelser indenfor sundhed og/eller lægemiddeludvikling.
Address
Langs Hegnet 88
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 110 | 127 | 142 | 714 | 832 | 378 | 593 | 258 | 653 | 400 | 386 |
| Staff expenses | -179 | -221 | -95 | -490 | -593 | -294 | -308 | -366 | -495 | -442 | -83 |
| EBITDA | -69 | -94 | 47 | 225 | 238 | 84 | 285 | -108 | 158 | -42 | 303 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -69 | -94 | 47 | 225 | 238 | 84 | 285 | -108 | 158 | -42 | 303 |
| Net financials | -1 | 0 | -0 | 0 | -1 | -2 | -4 | -4 | -1 | 0 | 2 |
| Profit before tax | -70 | -94 | 47 | 225 | 237 | 82 | 281 | -112 | 157 | -42 | 305 |
| Tax | -0 | -0 | -0 | 51 | 54 | 20 | -0 | -22 | 38 | -7 | 70 |
| Net profit | -70 | -94 | 47 | 174 | 183 | 62 | 215 | -89 | 119 | -35 | 234 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 232 | 13 | 99 | 424 | 586 | 399 | 627 | 437 | 463 | 341 | 553 |
| Equity | -20 | -114 | -67 | 107 | 237 | 199 | 414 | 268 | 329 | 235 | 409 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 252 | 127 | 166 | 317 | 349 | 200 | 213 | 169 | 134 | 106 | 144 |
| Total debt | 252 | 127 | 166 | 317 | 349 | 200 | 213 | 169 | 134 | 106 | 144 |
EBITDA margin
78.5%
This company
15.8%
Market median
+397% vs market
20152025
Equity ratio
73.9%
This company
38.2%
Market median
+93% vs market
20152025
Return on equity
57.4%
This company
18.4%
Market median
+212% vs market
20152025
Net profit margin
60.8%
This company
8.1%
Market median
+651% vs market
20152025
Asset turnover
0.70×
This company
1.12×
Market median
-38% vs market
20152025
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
20152025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-08-18 – 2015-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AS Management | Management | 2014 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Helms & Sams ApS | Company | 100.0% | 100.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Helms & Sams ApS
Biologik ApS Board members of Biologik ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anette Sams Nielsen | Management | 0 companies |